Charles Schwab’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.4M | Buy |
1,429,842
+73,343
| +5% | +$1.75M | 0.01% | 1399 |
|
|
2025
Q4 | $31.7M | Buy |
1,356,499
+24,509
| +2% | +$546K | ﹤0.01% | 1454 |
|
|
2025
Q3 | $26.2M | Sell |
1,331,990
-104,122
| -7% | -$2.14M | ﹤0.01% | 1571 |
|
|
2025
Q2 | $31.2M | Buy |
1,436,112
+109,341
| +8% | +$2.58M | 0.01% | 1410 |
|
|
2025
Q1 | $32.2M | Buy |
1,326,771
+79,846
| +6% | +$1.8M | 0.01% | 1358 |
|
|
2024
Q4 | $26M | Buy |
1,246,925
+79,182
| +7% | +$1.7M | ﹤0.01% | 1557 |
|
|
2024
Q3 | $23.2M | Buy |
1,167,743
+50,804
| +5% | +$942K | ﹤0.01% | 1620 |
|
|
2024
Q2 | $17.3M | Buy |
1,116,939
+41,380
| +4% | +$644K | ﹤0.01% | 1767 |
|
|
2024
Q1 | $17.1M | Buy |
1,075,559
+119,226
| +12% | +$1.8M | ﹤0.01% | 1702 |
|
|
2023
Q4 | $16.1M | Buy |
956,333
+35,006
| +4% | +$479K | ﹤0.01% | 1720 |
|
|
2023
Q3 | $10.8M | Buy |
921,327
+58,018
| +7% | +$776K | ﹤0.01% | 1875 |
|
|
2023
Q2 | $11.6M | Sell |
863,309
-355,866
| -29% | -$5.12M | ﹤0.01% | 1844 |
|
|
2023
Q1 | $20.2M | Sell |
1,219,175
-28,239
| -2% | -$466K | 0.01% | 1465 |
|
|
2022
Q4 | $23.2M | Buy |
1,247,414
+31,503
| +3% | +$485K | 0.01% | 1333 |
|
|
2022
Q3 | $15.6M | Buy |
1,215,911
+34,504
| +3% | +$409K | 0.01% | 1556 |
|
|
2022
Q2 | $8.28M | Buy |
1,181,407
+350,042
| +42% | +$2.57M | ﹤0.01% | 1935 |
|
|
2022
Q1 | $6.89M | Buy |
831,365
+11,569
| +1% | +$81.8K | ﹤0.01% | 2128 |
|
|
2021
Q4 | $5.55M | Buy |
819,796
+18,552
| +2% | +$122K | ﹤0.01% | 2302 |
|
|
2021
Q3 | $4.25M | Buy |
801,244
+2,005
| +0.3% | +$11K | ﹤0.01% | 2453 |
|
|
2021
Q2 | $4.6M | Sell |
799,239
-170,468
| -18% | -$880K | ﹤0.01% | 2393 |
|
|
2021
Q1 | $4.47M | Sell |
969,707
-25,033
| -3% | -$99.5K | ﹤0.01% | 2352 |
|
|
2020
Q4 | $3.32M | Buy |
994,740
+94,442
| +10% | +$317K | ﹤0.01% | 2416 |
|
|
2020
Q3 | $2.67M | Sell |
900,298
-5,295
| -0.6% | -$20.7K | ﹤0.01% | 2387 |
|
|
2020
Q2 | $4.18M | Buy |
905,593
+40,734
| +5% | +$183K | ﹤0.01% | 2106 |
|
|
2020
Q1 | $3.33M | Buy |
864,859
+55,039
| +7% | +$226K | ﹤0.01% | 2044 |
|
|
2019
Q4 | $3.04M | Buy |
809,820
+238,842
| +42% | +$1.12M | ﹤0.01% | 2273 |
|
|
2019
Q3 | $3.03M | Buy |
570,978
+344,790
| +152% | +$1.84M | ﹤0.01% | 2224 |
|
|
2019
Q2 | $869K | Hold |
226,188
| – | – | ﹤0.01% | 2619 |
|
|
2019
Q1 | $1.15M | Buy |
226,188
+17,784
| +9% | +$52.3K | ﹤0.01% | 2518 |
|
|
2018
Q4 | $401K | Hold |
208,404
| – | – | ﹤0.01% | 2842 |
|
|
2018
Q3 | $788K | Hold |
208,404
| – | – | ﹤0.01% | 2698 |
|
|
2018
Q2 | $651K | Buy |
208,404
+23,500
| +13% | +$71.3K | ﹤0.01% | 2709 |
|
|
2018
Q1 | $442K | Buy |
184,904
+36,200
| +24% | +$120K | ﹤0.01% | 2767 |
|
|
2017
Q4 | $582K | Buy |
148,704
+28,204
| +23% | +$93.2K | ﹤0.01% | 2689 |
|
|
2017
Q3 | $304K | Hold |
120,500
| – | – | ﹤0.01% | 2865 |
|
|
2017
Q2 | $333K | Buy |
+120,500
| New | +$251K | ﹤0.01% | 2825 |
|
|
2016
Q2 | – | Sell |
-107,345
| Closed | -$126K | – | 3115 |
|
|
2016
Q1 | $126K | Hold |
107,345
| – | – | ﹤0.01% | 2964 |
|
|
2015
Q4 | $263K | Hold |
107,345
| – | – | ﹤0.01% | 2902 |
|
|
2015
Q3 | $323K | Hold |
107,345
| – | – | ﹤0.01% | 2798 |
|
|
2015
Q2 | $444K | Buy |
+107,345
| New | +$428K | ﹤0.01% | 2715 |
|
Other funds holding CPRX
VCM
DM
VPM